Treponema pallidum, Microhemagglutination
The microhemagglutination (MHA) Treponema pallidum (TP) test measures specific antibody against T. pallidum, the organism that causes syphilis, in a patient's serum by agglutination of T. pallidum antigen-coated erythrocytes. The tests are based on cardiolipin-type antigen, which detects “reagin,” an antibody-like substance present in serum from syphilitic persons, and occasionally in serum of persons with other acute and chronic conditions. However, reactivity in these tests generally indicates host tissue damage that may not be specific for syphilis.
This test is used to confirm reactive serologic tests for syphilis (RPR or VDRL). In addition, it is used to monitor the treatment (titer). Sensitivity in the primary stages of syphilis is decreased, but equal to the fluorescent treponemal antibody absorption test (FTA-ABS) in the secondary and latent stages. False positives also may occur in patients with systemic lupus erythematosus, infectious mononucleosis, drug addiction, collagen disease, or leprosy. This test cannot be used to test CSF specimens.
- Diagnosis of syphilis
- Confirmatory serologic test for syphilis
- Treatment monitoring
Increased in:
- Primary syphilis
- Secondary syphilis
- Late latent syphilis
- Tertiary syphilis
- Infectious mononucleosis
- Collagen-vascular diseases
- Hyperglobulinemia
- Dysglobulinemia
Negative (Non-Reactive)
Serum Red top preferred, Serum gel (SST) acceptable.
Stability
- Ambient: 1-3 days
- Refrigerated: 5-7 days
- Frozen: 30 days
- Clin Microbiol Rev. 1995;8:1. [PMID: 7704889]
- Dermatol Clin. 1998 Oct;16(4):691-8. [PMID: 9891668]
- Clin Microbiol Rev. 1995 Jan;8(1):1-21. [PMID: 7704889]
- J Emerg Med. 2000 Apr;18(3):361-7. [PMID: 10729677]
- Jacobs DS and DeMott WR. Laboratory Test Handbook. 5th. Hudson, OH. Lexi-Comp, Inc (2001).
- Przegl Epidemiol. 2009;63(4):519-23. [PMID: 20120950]